LONDON - Ark Therapeutics Group Ltd. has confirmed plans for an initial public offering to raise £55 million (US$104.7 million), a move that will be followed closely by those at cash-starved companies across Europe who are waiting for the IPO window to open. (BioWorld International) Read More
